标题
Targeted Protein Degraders- The druggability perspective
作者
关键词
-
出版物
JOURNAL OF PHARMACEUTICAL SCIENCES
Volume -, Issue -, Pages -
出版商
Elsevier BV
发表日期
2023-11-04
DOI
10.1016/j.xphs.2023.10.023
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Trial in progress: A phase 1, first-in-human, open-label, multicenter, dose-escalation and dose-expansion study of ASP3082 in patients with previously treated advanced solid tumors and KRAS G12D mutations.
- (2023) Anthony W. Tolcher et al. JOURNAL OF CLINICAL ONCOLOGY
- Application of Novel Degraders Employing Autophagy for Expediting Medicinal Research
- (2023) Xiang Li et al. Journal of Medicinal Chemistry
- The Dawn of a New Era: Targeting the “Undruggables” with Antibody-Based Therapeutics
- (2023) Linghui Qian et al. Chemical Reviews
- Industry Perspective on the Pharmacokinetic and Absorption, Distribution, Metabolism, and Excretion Characterization of Heterobifunctional Protein Degraders
- (2023) Laurie P. Volak et al. DRUG METABOLISM AND DISPOSITION
- Targeted Protein Degradation: A Promising Option for Cancer Drug Developers
- (2023) Tiffany Yesavage Genetic Engineering & Biotechnology News
- Bioorthogonal PROTAC Prodrugs Enabled by On-Target Activation
- (2023) Mengyang Chang et al. Journal of the American Chemical Society
- Stimuli-activatable PROTACs for precise protein degradation and cancer therapy
- (2023) Jing Gao et al. Science Bulletin
- Targeting BCMA in Multiple Myeloma: Advances in Antibody-Drug Conjugate Therapy
- (2023) Lijie Xing et al. Cancers
- Novel bispecific aptamer targeting PD-1 and nucleolin for cancer immunotherapy
- (2023) Junjun Fu et al. Cancer Nanotechnology
- Targeted Protein Degradation: Advances, Challenges, and Prospects for Computational Methods
- (2023) Barmak Mostofian et al. Journal of Chemical Information and Modeling
- Targeted delivery of PROTAC-based prodrug activated by bond-cleavage bioorthogonal chemistry for microneedle-assisted cancer therapy
- (2023) Jing Huang et al. JOURNAL OF CONTROLLED RELEASE
- Impact of PROTAC Linker Plasticity on the Solution Conformations and Dissociation of the Ternary Complex
- (2022) Dhanushka Weerakoon et al. Journal of Chemical Information and Modeling
- PROTAC targeted protein degraders: the past is prologue
- (2022) Miklós Békés et al. NATURE REVIEWS DRUG DISCOVERY
- Options to Improve the Action of PROTACs in Cancer: Development of Controlled Delivery Nanoparticles
- (2022) Alberto Juan et al. Frontiers in Cell and Developmental Biology
- Roadmap for Optimizing and Broadening Antibody-Based PROTACs for Degradation of Cell Surface Proteins
- (2022) Josef A. Gramespacher et al. ACS Chemical Biology
- Multifaceted targeted protein degradation systems for different cellular compartments
- (2022) Cornelia E. Zorca et al. BIOESSAYS
- Strategies to Reduce the On‐Target Platelet Toxicity of Bcl‐x L Inhibitors: PROTACs, SNIPERs and Prodrug‐Based Approaches
- (2022) Arvind Negi et al. CHEMBIOCHEM
- Designing Soluble PROTACs: Strategies and Preliminary Guidelines
- (2022) Diego García Jiménez et al. JOURNAL OF MEDICINAL CHEMISTRY
- Chaperone-Mediated Autophagy: A Potential Target for Metabolic Diseases
- (2022) Ming Yang et al. CURRENT MEDICINAL CHEMISTRY
- Targeting androgen receptor for prostate cancer therapy: From small molecules to PROTACs
- (2022) Ioannis Avgeris et al. BIOORGANIC CHEMISTRY
- BRD4 PROTAC degrader MZ1 exerts anticancer effects in acute myeloid leukemia by targeting c-Myc and ANP32B genes
- (2022) Li Ma et al. CANCER BIOLOGY & THERAPY
- New steps on an old path: novel estrogen receptor inhibitors in breast cancer
- (2022) Martina Pagliuca et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- Recent advances in the development of EGFR degraders: PROTACs and LYTACs
- (2022) Dawei Hong et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Selective PARP1 Inhibitors, PARP1-based Dual-Target Inhibitors, PROTAC PARP1 Degraders, and Prodrugs of PARP1 Inhibitors for Cancer Therapy
- (2022) Xiaopeng Peng et al. PHARMACOLOGICAL RESEARCH
- Targeted Protein Degradation: Clinical Advances in the Field of Oncology
- (2022) Abdelrahman K. A. A. Salama et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- The therapeutic prospects of N-acetylgalactosamine-siRNA conjugates
- (2022) Lei Zhang et al. Frontiers in Pharmacology
- Aptamer-Based Probes for Cancer Diagnostics and Treatment
- (2022) Xueqi Hu et al. Life-Basel
- Development of Antibody-Based PROTACs for the Degradation of the Cell-Surface Immune Checkpoint Protein PD-L1
- (2021) Adam D. Cotton et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- Development of Triantennary N-Acetylgalactosamine Conjugates as Degraders for Extracellular Proteins
- (2021) Yaxian Zhou et al. ACS Central Science
- LYTACs that engage the asialoglycoprotein receptor for targeted protein degradation
- (2021) Green Ahn et al. Nature Chemical Biology
- From Conception to Development: Investigating PROTACs Features for Improved Cell Permeability and Successful Protein Degradation
- (2021) Carlotta Cecchini et al. Frontiers in Chemistry
- Ubiquitination, Biotech Startups, and the Future of TRIM Family Proteins: A TRIM-Endous Opportunity
- (2021) Utsa Bhaduri et al. Cells
- 564TiP A phase Ib dose-escalation study of ZN-c5, an oral selective estrogen receptor degrader (SERD), in combination with abemaciclib in patients with advanced estrogen receptor (ER)+/HER2- breast cancer
- (2021) G.P. Keogh et al. ANNALS OF ONCOLOGY
- LYTACs: An Emerging Tool for the Degradation of Non‐Cytosolic Proteins
- (2021) Bhavana Ramadas et al. ChemMedChem
- Molecular Glues for Targeted Protein Degradation: From Serendipity to Rational Discovery
- (2021) Guoqiang Dong et al. JOURNAL OF MEDICINAL CHEMISTRY
- Lysosome-targeting chimeras evolve
- (2021) Joshiawa Paulk Nature Chemical Biology
- Small molecule probes for targeting autophagy
- (2021) Thomas Whitmarsh-Everiss et al. Nature Chemical Biology
- Advances in PSMA-targeted therapy for prostate cancer
- (2021) Fujin Wang et al. PROSTATE CANCER AND PROSTATIC DISEASES
- Liver-Targeted Delivery of Oligonucleotides with N-Acetylgalactosamine Conjugation
- (2021) Hao Cui et al. ACS Omega
- Overcoming Gemcitabine Resistance in Pancreatic Cancer Using the BCL-XL–Specific Degrader DT2216
- (2021) Dinesh Thummuri et al. MOLECULAR CANCER THERAPEUTICS
- Targeting cancer metabolism in the era of precision oncology
- (2021) Zachary E. Stine et al. NATURE REVIEWS DRUG DISCOVERY
- Antibody–PROTAC Conjugates Enable HER2-Dependent Targeted Protein Degradation of BRD4
- (2020) Marı́a Maneiro et al. ACS Chemical Biology
- First-in-human phase I study of ARV-110, an androgen receptor (AR) PROTAC degrader in patients (pts) with metastatic castrate-resistant prostate cancer (mCRPC) following enzalutamide (ENZ) and/or abiraterone (ABI).
- (2020) Daniel Peter Petrylak et al. JOURNAL OF CLINICAL ONCOLOGY
- Proteolysis-targeting chimera (PROTAC) for targeted protein degradation and cancer therapy
- (2020) Xin Li et al. Journal of Hematology & Oncology
- Targeted protein degradation: current and future challenges
- (2020) Alexander Hanzl et al. CURRENT OPINION IN CHEMICAL BIOLOGY
- DT2216—a Bcl-xL-specific degrader is highly active against Bcl-xL-dependent T cell lymphomas
- (2020) Yonghan He et al. Journal of Hematology & Oncology
- Receptor-Specific Delivery of Peptide Nucleic Acids Conjugated to Three Sequentially Linked N-Acetyl Galactosamine Moieties into Hepatocytes
- (2020) Pramod Bhingardeve et al. JOURNAL OF ORGANIC CHEMISTRY
- Understanding and Improving the Membrane Permeability of VH032-Based PROTACs
- (2020) Victoria G. Klein et al. ACS Medicinal Chemistry Letters
- Modeling the Degradation Effects of Autophagosome Tethering Compounds
- (2020) Hang Zhang et al. Neuroscience Bulletin
- Solution Conformations Shed Light on PROTAC Cell Permeability
- (2020) Yoseph Atilaw et al. ACS Medicinal Chemistry Letters
- Recent advances in the determination of unbound concentration and plasma protein binding of drugs: Analytical methods
- (2020) Behrouz Seyfinejad et al. TALANTA
- Lipid-Based Nanocarriers for Lymphatic Transportation
- (2019) Nikhar Vishwakarma et al. AAPS PHARMSCITECH
- Targeting IRAK4 for Degradation with PROTACs
- (2019) Joao Nunes et al. ACS Medicinal Chemistry Letters
- A novel asymmetrical anti-HER2/CD3 bispecific antibody exhibits potent cytotoxicity for HER2-positive tumor cells
- (2019) Shengnan Yu et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Development of targeted protein degradation therapeutics
- (2019) Philip P. Chamberlain et al. Nature Chemical Biology
- Degradation of proteins by PROTACs and other strategies
- (2019) Yang Wang et al. Acta Pharmaceutica Sinica B
- Development of a PDEδ-Targeting PROTACs that Impair Lipid Metabolism
- (2019) Michael Winzker et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- AUTACs: Cargo-Specific Degraders Using Selective Autophagy
- (2019) Daiki Takahashi et al. MOLECULAR CELL
- Selective degradation of BET proteins with dBET1, a proteolysis-targeting chimera, potently reduces pro-inflammatory responses in lipopolysaccharide-activated microglia
- (2018) Kelly M. DeMars et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Glutamic acid–valine–citrulline linkers ensure stability and efficacy of antibody–drug conjugates in mice
- (2018) Yasuaki Anami et al. Nature Communications
- GalNAc-siRNA Conjugates: Leading the Way for Delivery of RNAi Therapeutics
- (2018) Aaron D. Springer et al. Nucleic Acid Therapeutics
- Squeezing for Life – Properties of Red Blood Cell Deformability
- (2018) Rick Huisjes et al. Frontiers in Physiology
- Unraveling the interaction between carboxylesterase 1c and the antibody-drug conjugate SYD985: improved translational PKPD by using CES1c knockout mice
- (2018) Ruud Ubink et al. MOLECULAR CANCER THERAPEUTICS
- Synergistic targeting HER2 and EGFR with a bivalent aptamer-siRNA chimera efficiently inhibits HER2-positive tumor growth
- (2018) LU XUE et al. MOLECULAR PHARMACEUTICS
- Lipophilic Permeability Efficiency Reconciles the Opposing Roles of Lipophilicity in Membrane Permeability and Aqueous Solubility
- (2018) Matthew R. Naylor et al. JOURNAL OF MEDICINAL CHEMISTRY
- Aptamer Chimeras for Therapeutic Delivery: The Challenging Perspectives
- (2018) Carla Esposito et al. Genes
- Autophagy-regulating protease Atg4: structure, function, regulation and inhibition
- (2017) Tatsuro Maruyama et al. JOURNAL OF ANTIBIOTICS
- Sulphonamide inhibition studies of the β-carbonic anhydrase from the bacterial pathogen Clostridium perfringens
- (2017) Daniela Vullo et al. JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY
- Impact of Target Warhead and Linkage Vector on Inducing Protein Degradation: Comparison of Bromodomain and Extra-Terminal (BET) Degraders Derived from Triazolodiazepine (JQ1) and Tetrahydroquinoline (I-BET726) BET Inhibitor Scaffolds
- (2017) Kwok-Ho Chan et al. JOURNAL OF MEDICINAL CHEMISTRY
- Nonclassical Size Dependence of Permeation Defines Bounds for Passive Adsorption of Large Drug Molecules
- (2017) Cameron R. Pye et al. JOURNAL OF MEDICINAL CHEMISTRY
- Targeting autophagy to overcome chemoresistance in acute myleogenous leukemia
- (2016) Sujan Piya et al. Autophagy
- Passive Membrane Permeability in Cyclic Peptomer Scaffolds Is Robust to Extensive Variation in Side Chain Functionality and Backbone Geometry
- (2016) Akihiro Furukawa et al. JOURNAL OF MEDICINAL CHEMISTRY
- Exploring experimental and computational markers of cyclic peptides: Charting islands of permeability
- (2015) Conan K. Wang et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Differences in Rat and Human Erythrocytes Following Blood Component Manufacturing: The Effect of Additive Solutions
- (2015) Luciana da SilveiraCavalcante et al. TRANSFUSION MEDICINE AND HEMOTHERAPY
- Multifunctional Lactobionic Acid-Modified Dendrimers for Targeted Drug Delivery to Liver Cancer Cells: Investigating the Role Played by PEG Spacer
- (2014) Fanfan Fu et al. ACS Applied Materials & Interfaces
- Exploring the Impact of Drug Properties on the Extent of Intestinal Lymphatic Transport - In Vitro and In Vivo Studies
- (2014) Emma Lawless et al. PHARMACEUTICAL RESEARCH
- Species differences in drug plasma protein binding
- (2014) Nicola Colclough et al. MedChemComm
- Species Difference of Esterase Expression and Hydrolase Activity in Plasma
- (2012) Fatma Goksin Bahar et al. JOURNAL OF PHARMACEUTICAL SCIENCES
- Comparative Analysis of Esterase Activities of Human, Mouse, and Rat Blood
- (2011) E. V. Rudakova et al. BULLETIN OF EXPERIMENTAL BIOLOGY AND MEDICINE
- Hepatocyte Targeting and Intracellular Copper Chelation by a Thiol-Containing Glycocyclopeptide
- (2010) Anaïs M. Pujol et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- The Genome of the Western Clawed Frog Xenopus tropicalis
- (2010) U. Hellsten et al. SCIENCE
- The role of molecular physicochemical properties and apolipoproteins in association of drugs with triglyceride-rich lipoproteins: in-silico prediction of uptake by chylomicrons
- (2009) Pavel Gershkovich et al. JOURNAL OF PHARMACY AND PHARMACOLOGY
- In Vitro and in Vivo Studies on Plasma-to-Blood Ratio of Paclitaxel in Human, Rabbit and Rat Blood Fractions
- (2008) Xiang-Rui Liu et al. BIOLOGICAL & PHARMACEUTICAL BULLETIN
- Physiochemical drug properties associated with in vivo toxicological outcomes
- (2008) Jason D. Hughes et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Generation of a Set of Simple, Interpretable ADMET Rules of Thumb
- (2008) M. Paul Gleeson JOURNAL OF MEDICINAL CHEMISTRY
- Deep Coverage Mouse Red Blood Cell Proteome
- (2008) Erica M. Pasini et al. MOLECULAR & CELLULAR PROTEOMICS
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now